George Freeman FRSA

After a 15yr career in UK Life Science Venture finance – as Director of Early Stage Ventures at Merlin Biosciences 1997-2001, CEO of Amedis Pharma before its merger with Paradigm & sale to Takeda, and Founding CEO of 4D Biomedical – George was elected to Parliament in 2010 and has held a number of key Science & Technology Ministerial roles under 4 Prime Ministers over the last 14years, representing the UK at successive G7 & G20 Science Summits, overseeing the UK’s renegotiation to the European Horizon R+D & negotiating the UK’s S+T Collaborations with Canada, Japan, Israel & Switzerland.

As the UK’s first Minister for Life Science, George led the UK’s 10yr Life Science Industrial Strategy in 2011, launching Genomics England, the Dementia Research Institute, the Accelerated Access reforms, UK Clinical Trials